Smith & Nephew plc (SNN)
Market Cap | 10.76B |
Revenue (ttm) | 5.55B |
Net Income (ttm) | 263.00M |
Shares Out | 435.97M |
EPS (ttm) | 0.60 |
PE Ratio | 40.84 |
Forward PE | 12.08 |
Dividend | $0.75 (3.04%) |
Ex-Dividend Date | Apr 1, 2024 |
Volume | 485,868 |
Open | 24.45 |
Previous Close | 24.51 |
Day's Range | 24.43 - 24.74 |
52-Week Range | 21.53 - 31.31 |
Beta | 0.57 |
Analysts | Strong Buy |
Price Target | 33.00 (+33.71%) |
Earnings Date | Aug 1, 2024 |
About SNN
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other... [Read more]
Financial Performance
In 2023, Smith & Nephew's revenue was $5.55 billion, an increase of 6.40% compared to the previous year's $5.22 billion. Earnings were $263.00 million, an increase of 17.94%.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for SNN stock is "Strong Buy." The 12-month stock price forecast is $33.0, which is an increase of 33.71% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/h/q/press16-2362055.jpg)
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, anno...
![](https://cdn.snapi.dev/images/v1/b/i/press3-2356902.jpg)
Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE)...
![](https://cdn.snapi.dev/images/v1/b/c/press6-2349566.jpg)
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centr...
![](https://cdn.snapi.dev/images/v1/s/f/press4-2339516.jpg)
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world's premier mixed martial ar...
![](https://cdn.snapi.dev/images/v1/j/u/press15-2273189.jpg)
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use wit...
![](https://cdn.snapi.dev/images/v1/f/s/press14-2272203.jpg)
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting
Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* fo...
![](https://cdn.snapi.dev/images/v1/7/f/press13-2271243.jpg)
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the REGENET...
![](https://cdn.snapi.dev/images/v1/d/7/press2-2228806.jpg)
Australia's approach to musculoskeletal injury care and reimbursement demands rethink: Report
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a new report examining musculoskeletal injury care and reimbursement in Australia that urges health payers and ...
![](https://cdn.snapi.dev/images/v1/z/t/press12-2225354.jpg)
New study confirms Smith+Nephew's REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%
First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears
![](https://cdn.snapi.dev/images/v1/x/l/press17-2098096.jpg)
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich
LONDON , Oct. 11, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased ...
![](https://cdn.snapi.dev/images/v1/m/i/press20-1930271.jpg)
Smith+Nephew announces 510(k) clearance of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement
LONDON , June 12, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food and Drug Adm...
![](https://cdn.snapi.dev/images/v1/y/a/press15-1892021.jpg)
Smith+Nephew helps personalize robotically-enabled surgery with AI-powered planning software and data visualization platform
LONDON , May 16, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduces two key products that close the feedback loop for its robotics and digita...
![](https://cdn.snapi.dev/images/v1/t/e/press3-1865249.jpg)
Smith+Nephew receives Innovative Technology contract from Vizient for PICO™ Single Use Negative Pressure Wound Therapy Systems
Contract awarded for products that bring improvement to healthcare industry LONDON , May 2, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announc...
![](https://cdn.snapi.dev/images/v1/e/k/press19-1849732.jpg)
Smith+Nephew introduces first of its kind handheld digital tensioning device for robotically-enabled total knee arthroplasty
LONDON , April 24, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built device that lets surg...
![](https://cdn.snapi.dev/images/v1/x/2/press2-1809532.jpg)
New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
LONDON , March 23, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces results from new scientific research that shows its COBLATION Intracapsu...
![](https://cdn.snapi.dev/images/v1/0/l/press14-1787212.jpg)
Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting
LONDON , March 8, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN) (NYSE:SNN), the global medical technology company, today announces it will showcase its latest Sports Medicine procedural innovations for j...
![](https://cdn.snapi.dev/images/v1/w/r/press17-1785677.jpg)
Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting
An uncompromising commitment to freedom of movement LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today unveils "Precision in Motion"...
![](https://cdn.snapi.dev/images/v1/i/c/press8-1785320.jpg)
Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction
LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced the UltraTRAC™ QUAD ACL Reconstruction Technique which consists of the n...
![](https://cdn.snapi.dev/images/v1/f/9/press19-1783365.jpg)
Smith+Nephew's VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation
LONDON , March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Patient...
![](https://cdn.snapi.dev/images/v1/0/z/press20-1728613.jpg)
Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System
Designation recognizes Vizient-contracted products that bring improvements to healthcare industry LONDON , Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology ...
![](https://cdn.snapi.dev/images/v1/j/z/medical12-1723201.jpg)
Smith & Nephew Is Reverting to Fair Value
The medical device industry has undergone considerable consolidation in recent years, leaving a small number of competitors, and offers long-term growth potential due to increasing longevity, an aging...
![](https://cdn.snapi.dev/images/v1/d/1/press3-1610110.jpg)
Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution
LONDON , Nov. 1, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hyb...
![](https://cdn.snapi.dev/images/v1/m/0/press10-1557566.jpg)
Smith+Nephew first to market with revision knee indication on robotics platform
LONDON , Sept. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the first cases for revision knee replacement utilizing its CORI◊ Surgic...
![](https://cdn.snapi.dev/images/v1/2/7/press13-1552439.jpg)
Smith+Nephew Academy expands global access to professional medical education through virtual reality and other advanced simulation technologies
LONDON , Sept. 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it is expanding the reach of its medical education curriculum through a ...
![](https://cdn.snapi.dev/images/v1/e/o/press10-1543734.jpg)
New randomized controlled trial shows that addition of Smith+Nephew's REGENETEN™ Bioinductive Implant delivers 86% reduction in rotator cuff re-tear rates at 12 months
LONDON , Sept. 14, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE: SNN), the global medical technology company, today announces promising new data furthering a number of published studies supporting ...